FTHFaeth Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 15684
Ticker: FTH
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-02-04
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: FTH

Detail

Enriched 2026-08-14 20:47

Market cap: $759,191,686.5
Shares outstanding (class): 25,840,425
Shares outstanding (weighted): 25,840,425
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 29
Location: AUSTIN, TX
Homepage: https://www.faeththerapeutics.com
Description: Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Market cap and share counts drift.

Funds holding this security

1 funds · 1 positions · $244.3K reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$244.3K	0.00%	7,750 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERFTH
FIGI_COMPOSITEBBG00V3M3TP5
FIGI_SHARE_CLASSBBG00V3M3TR3
CIK0001829802
ISINUS81728A2078
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: The security is common stock of a pharmaceutical preparations company, fitting the healthcare sector and pharmaceuticals industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.